Valuation: GSK plc

Market Cap 74.49B 97.88B 89.27B 82.54B 140B 9,147B 146B 997B 394B 4,937B 367B 360B 15,590B P/E 2026 *
15.1x
P/E 2027 * 12x
Enterprise Value 96.38B 127B 116B 107B 182B 11,835B 189B 1,290B 510B 6,388B 475B 465B 20,171B EV / Sales 2026 *
2.85x
EV / Sales 2027 * 2.66x
Free-Float
94.95%
Yield 2026 *
3.74%
Yield 2027 * 4.03%
1 day-1.35%
1 week-3.42%
Current month-1.02%
1 month-1.02%
3 months-4.18%
6 months-3.47%
Current year+0.63%
1 week 1,820.5
Extreme 1820.5
1,950
1 month 1,783.5
Extreme 1783.5
1,950
Current year 1,690
Extreme 1690
2,282
1 year 1,690
Extreme 1690
2,282
3 years 1,242.5
Extreme 1242.5
2,282
5 years 1,242.5
Extreme 1242.5
3,408.16
10 years 1,242.5
Extreme 1242.5
3,408.16
Manager TitleAgeSince
Chief Executive Officer 52 01/01/2026
Director of Finance/CFO 64 01/05/2023
Compliance Officer - 01/08/2018
Director TitleAgeSince
Director/Board Member 52 06/05/2026
Director/Board Member 64 01/01/2018
Chairman 67 01/09/2019
Date Insider Type Main position Quantity % Market Cap. Importance
10/22/26 A Buy

Executive/Senior Manager

9 0.0000%
10/13/26 A Buy

Executive/Senior Manager

352 0.0000%
10/13/26 A Buy

Compliance Officer

326 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.36%-3.42%+3.58%+30.40% 97.88B
-1.97%-4.16%+30.32%+128.90% 1,232B
-2.14%-5.86%+31.80%+78.05% 656B
-1.06%-3.86%+21.54%+104.67% 506B
-0.81%-1.35%+29.27%+69.09% 382B
-2.17%-8.15%+42.00%+31.45% 340B
-2.70%-4.47%+25.44%+52.14% 294B
-1.69%-3.43%-1.06%+33.11% 278B
-0.78%-5.40%+29.04%+66.52% 240B
-1.30%-0.22%+30.85%+120.51% 210B
Average -1.60%-2.23%+24.28%+71.48% 424B
Weighted average by Cap. -1.71%-2.65%+27.28%+87.06%

Financials

2026 *2027 *
Net sales 33.83B 44.46B 40.55B 37.49B 63.72B 4,155B 66.23B 453B 179B 2,242B 167B 163B 7,081B 35.28B 46.36B 42.28B 39.09B 66.44B 4,332B 69.06B 472B 187B 2,338B 174B 170B 7,383B
Net income 4.92B 6.46B 5.89B 5.45B 9.26B 604B 9.63B 65.81B 26.02B 326B 24.24B 23.74B 1,029B 6.11B 8.03B 7.32B 6.77B 11.51B 750B 11.96B 81.76B 32.32B 405B 30.12B 29.49B 1,279B
Net Debt 21.89B 28.77B 26.24B 24.26B 41.23B 2,688B 42.85B 293B 116B 1,451B 108B 106B 4,582B 19.18B 25.2B 22.98B 21.25B 36.12B 2,355B 37.54B 257B 101B 1,271B 94.54B 92.56B 4,014B
Projected Income Statement - Annual - GSK plc
Logo GSK plc
GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).
Employees
66,841
Date Price Change Volume
19/11/26 GBX 1,835.00 -1.24% 1,244,362
18/11/26 GBX 1,858.00 -0.59% 4,360,879
17/11/26 GBX 1,869.00 -3.14% 7,867,700
16/11/26 GBX 1,929.50 +0.94% 3,702,287
13/11/26 GBX 1,911.50 +0.55% 3,101,289
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - GSK plc
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
18.58GBP
Average target price
21.47GBP
Spread / Average Target
+15.57%